This is the first prescription i've picked up and they said it was forty three dollars. I questioned it, and it ended up being five dollars, which isn't bad.
The new regime is bedding down and in the ascendancy.
The price is extremely racy. They have to seriously turn this business around to justify what they've paid for it.
I don't think it is a complete slam dunk given the noises that one of the larger shareholders has been making.
The competitive environment is getting a lot nastier and opportunities for growth are a lot fewer.
This is something the man has done himself - it has nothing to do with the previous management. Eighteen months ago it was a pretty revolutionary target - it's good to get back to operational news again.
Copyright © 2024 Electric Goat Media. All Rights Reserved.